| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 176.47B | 175.42B | 152.86B | 132.81B | 118.43B |
| Gross Profit | 80.29B | 78.91B | 68.95B | 60.26B | 53.55B |
| EBITDA | 33.67B | 34.53B | 30.12B | 25.12B | 21.32B |
| Net Income | 20.15B | 17.83B | 13.14B | 11.29B | 9.73B |
Balance Sheet | |||||
| Total Assets | 193.10B | 194.34B | 184.59B | 171.25B | 159.34B |
| Cash, Cash Equivalents and Short-Term Investments | 61.69B | 67.82B | 65.30B | 65.76B | 63.56B |
| Total Debt | 14.68B | 15.33B | 13.86B | 12.21B | 8.97B |
| Total Liabilities | 53.88B | 57.77B | 56.48B | 49.61B | 43.07B |
| Stockholders Equity | 138.62B | 135.93B | 127.60B | 120.76B | 115.52B |
Cash Flow | |||||
| Free Cash Flow | 19.44B | 20.11B | 20.35B | 16.16B | 17.25B |
| Operating Cash Flow | 24.94B | 24.67B | 23.77B | 18.95B | 19.20B |
| Investing Cash Flow | -6.56B | -4.19B | -10.22B | -7.38B | -5.89B |
| Financing Cash Flow | -26.18B | -17.36B | -18.22B | -13.95B | -10.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥159.12B | 14.32 | ― | 3.23% | 5.32% | -3.12% | |
78 Outperform | ¥160.90B | 10.34 | ― | 1.68% | 9.88% | 14.45% | |
77 Outperform | ¥317.79B | 23.20 | ― | 1.49% | 8.80% | 8.09% | |
72 Outperform | ¥70.69B | 11.56 | ― | 2.31% | 3.34% | -8.24% | |
66 Neutral | ¥248.66B | 7.15 | 12.72% | 4.21% | 0.60% | 14.57% | |
65 Neutral | ¥49.80B | 16.90 | 6.12% | 2.67% | 14.75% | 183.28% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |